Consent in Pharmacogenomic research
| dc.contributor.author | Phillips, Michael S. | |
| dc.contributor.author | Joly, Yann | |
| dc.contributor.author | Silverstein, Tina | |
| dc.contributor.author | Avard, Denise | |
| dc.date.accessioned | 2008-04-15T15:30:22Z | |
| dc.date.available | 2008-04-15T15:30:22Z | |
| dc.date.issued | 2007 | |
| dc.identifier.uri | http://hdl.handle.net/1866/2262 | |
| dc.format.extent | 262619 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.publisher | GenEdit | en |
| dc.subject | Pharmacogenomic | |
| dc.subject | Genetic | |
| dc.subject | Ethic | |
| dc.subject | Legal | |
| dc.subject | Consent | |
| dc.title | Consent in Pharmacogenomic research | en |
| dc.type | Article | en |
| dc.contributor.affiliation | Université de Montréal. Faculté de droit | fr |
| dc.contributor.affiliation | Université de Montréal. Faculté de droit. Centre de recherche en droit public | fr |
| dcterms.abstract | This article analyzes the emerging ethical and legal requirements for informed consent in pharmacogenomic research. It reviews how policies at the international, regional and national levels have responded to the ethical challenges raised by this new research area. It concludes that the pharmacogenomic policy framework is still in its infancy and needs to be further developed to answer the challenges raised by this important discipline. | en |
| dcterms.description | [À l'origine dans / Was originally part of : CRDP - Droit, biotechnologie et rapport au milieu] | fr |
| dcterms.language | eng | en |
| UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | |
| oaire.citationTitle | GenEdit | |
| oaire.citationVolume | V | |
| oaire.citationIssue | 2 | |
| oaire.citationStartPage | 1 | |
| oaire.citationEndPage | 10 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.